Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Prestige Consumer Healthcare Inc.PBH · Entity 4350 | SVP Quality & Regulatory | May 07, 2025 | May 09, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Prestige Consumer Healthcare Inc.
Report date May 07, 2025 · Filed May 09, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | Direct | 17,051 |
Reported balance
After 2025-05-07 transaction · row 1
1 source rowRow 1 · 2025-05-07 · Tax withholding · Disposed 315 · Balance 17,051 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 06, 2019 Filed May 23, 2019 20:05 UTC Amendment | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | GrantEmployee Stock Option (right to buy) · Derivative | 7,622 | $0.00 Strike: $30.56 | $0.00 |
DisclosureSEC source: 0001144204-19-027969 · tv522373_4a.xml · derivative · entry 1 Fritz Mary Beth · CIK 0001749505 · Senior VP Quality & Regulatory 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,622 Underlying: Common Stock · 7,622 shares Expires 2029-05-06 F1 · derivative.exercise_price: This amendment is being filed to accurately reflect the exercise price of the options granted on May 6, 2019, which exercise price was inadvertently reported incorrectly in the original Form 4 filed on May 8, 2019. The correct exercise price is $30.56. F2 · derivative.exercise_date: The options vest in three annual installments as follows: 2,540 shares on May 6, 2020 and 2,541 shares each on May 6, 2021 and 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.